These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 26676833)

  • 1. Methylprednisolone-induced liver injury: Case report and literature review.
    Davidov Y; Har-Noy O; Pappo O; Achiron A; Dolev M; Ben-Ari Z
    J Dig Dis; 2016 Jan; 17(1):55-62. PubMed ID: 26676833
    [No Abstract]   [Full Text] [Related]  

  • 2. Methylprednisolone-induced acute liver injury in a patient treated for multiple sclerosis relapse.
    Bresteau C; Prevot S; Perlemuter G; Voican C
    BMJ Case Rep; 2018 Mar; 2018():. PubMed ID: 29507031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methylprednisolone-induced liver injury: a diagnostic challenge.
    Melamud B; Lurie Y; Goldin E; Levi I; Esayag Y
    Isr Med Assoc J; 2014 Mar; 16(3):180-1. PubMed ID: 24761710
    [No Abstract]   [Full Text] [Related]  

  • 4. Acute liver toxicity due to methylprednisolone: consider this diagnosis in the context of autoimmunity.
    Carrier P; Godet B; Crepin S; Magy L; Debette-Gratien M; Pillegand B; Jacques J; Sautereau D; Vidal E; Labrousse F; Gondran G; Loustaud-Ratti V
    Clin Res Hepatol Gastroenterol; 2013 Feb; 37(1):100-4. PubMed ID: 23318289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methylprednisolone-induced Toxic Hepatitis After Intravenous Pulsed Therapy for Multiple Sclerosis Relapses.
    Ferraro D; Mirante VG; Losi L; Villa E; Simone AM; Vitetta F; Federzoni L; Nichelli PF; Sola P
    Neurologist; 2015 Jun; 19(6):153-4. PubMed ID: 26075468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Recurrent acute liver toxicity from intravenous methylprednisolone].
    Rivero Fernández M; Riesco JM; Moreira VF; Moreno A; López San Román A; Arranz G; Ruiz Del Arbol L
    Rev Esp Enferm Dig; 2008 Nov; 100(11):720-3. PubMed ID: 19159178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incomplete septal cirrhosis after high-dose methylprednisolone therapy and regression of liver injury.
    Grilli E; Galati V; Petrosillo N; Del Nonno F; Baiocchini A
    Liver Int; 2015 Feb; 35(2):674-6. PubMed ID: 24906135
    [No Abstract]   [Full Text] [Related]  

  • 8. High-dose methylprednisolone-induced hepatitis in a patient with multiple sclerosis: a case report and brief review of literature.
    D'Agnolo HM; Drenth JP
    Neth J Med; 2013 May; 71(4):199-202. PubMed ID: 23723114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NORdic trial of oral Methylprednisolone as add-on therapy to Interferon beta-1a for treatment of relapsing-remitting Multiple Sclerosis (NORMIMS study): a randomised, placebo-controlled trial.
    Sorensen PS; Mellgren SI; Svenningsson A; Elovaara I; Frederiksen JL; Beiske AG; Myhr KM; Søgaard LV; Olsen IC; Sandberg-Wollheim M
    Lancet Neurol; 2009 Jun; 8(6):519-29. PubMed ID: 19409854
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-dose intravenous methylprednisolone: liver injury.
    Prescrire Int; 2015 Nov; 24(165):270. PubMed ID: 26688906
    [No Abstract]   [Full Text] [Related]  

  • 11. Recurrent acute hepatitis in patient receiving pulsed methylprednisolone for multiple sclerosis.
    Das D; Graham I; Rose J
    Indian J Gastroenterol; 2006; 25(6):314-6. PubMed ID: 17264438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylprednisolone induced liver injury in a patient with multiple sclerosis.
    Milovanovic T; Jankovic K; Boricic I; Dragasevic S; Stojkovic Lalosevic M; Dumic I
    J Gastrointestin Liver Dis; 2020 Mar; 29(1):119-120. PubMed ID: 32176748
    [No Abstract]   [Full Text] [Related]  

  • 13. Liver injury after methylprednisolone pulses: A disputable cause of hepatotoxicity. A case series and literature review.
    Zoubek ME; Pinazo-Bandera J; Ortega-Alonso A; Hernández N; Crespo J; Contreras F; Medina-Cáliz I; Sanabria-Cabrera J; Sanjuan-Jiménez R; González-Jiménez A; García-Cortés M; Lucena MI; Andrade RJ; Robles-Díaz M
    United European Gastroenterol J; 2019 Jul; 7(6):825-837. PubMed ID: 31316787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methylprednisolone-induced hepatotoxicity in a 16-year-old girl with multiple sclerosis.
    Rotondo E; Graziosi A; Di Stefano V; Mohn AA
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567201
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induced liver injury after high-dose methylprednisolone in a patient with multiple sclerosis.
    Oliveira AT; Lopes S; Cipriano MA; Sofia C
    BMJ Case Rep; 2015 Jul; 2015():. PubMed ID: 26199298
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver injury after pulsed methylprednisolone therapy in multiple sclerosis patients.
    Nociti V; Biolato M; De Fino C; Bianco A; Losavio FA; Lucchini M; Marrone G; Grieco A; Mirabella M
    Brain Behav; 2018 Jun; 8(6):e00968. PubMed ID: 29729087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methylprednisolone liver toxicity: A new case and a French regional pharmacovigilance survey.
    Dumortier J; Cottin J; Lavie C; Guillaud O; Hervieu V; Chambon-Augoyard C; Scoazec JY; Vukusic S; Vial T
    Clin Res Hepatol Gastroenterol; 2017 Sep; 41(4):497-501. PubMed ID: 28438569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RUCAM-based assessment of liver injury by xiang-tian-guo (Swietenia macrophylla) seeds, a plant used for treatment of hypertension and diabetes.
    Tan Y; Chen H; Zhou X; Sun L
    Ann Hepatol; 2019; 18(2):406-407. PubMed ID: 31056362
    [No Abstract]   [Full Text] [Related]  

  • 19. Suppressive effect of glucocorticoids on TNF-alpha production is associated with their clinical effect in multiple sclerosis.
    van Winsen LM; Polman CH; Dijkstra CD; Tilders FJ; Uitdehaag BM
    Mult Scler; 2010 Apr; 16(4):500-2. PubMed ID: 20086025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins may increase the risk of liver dysfunction in patients treated with steroids for active graves' orbitopathy.
    Covelli D; Vannucchi G; Campi I; Currò N; D'Ambrosio R; Maggioni M; Gianelli U; Beck-Peccoz P; Salvi M
    J Clin Endocrinol Metab; 2015 May; 100(5):1731-7. PubMed ID: 25751109
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.